首页|Department of Urology Reports Findings in Testicular Cancer (Clinical efficacy and safety of robotic retroperitoneal lymph node dissection for testicular cancer: a systematic review and meta-analysis)
Department of Urology Reports Findings in Testicular Cancer (Clinical efficacy and safety of robotic retroperitoneal lymph node dissection for testicular cancer: a systematic review and meta-analysis)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Oncology - Testicular Cancer is the subject of a report. Accordingto news reporting out of Lanzhou, People’s Republic of China, by NewsRx editors, research stated,“Retroperitoneal lymph node dissection (RPLND) is an effective treatment for testicular tumors. In recentyears, with the development of robotics, many urological procedures performed via standard laparoscopyhave been replaced by robots.”
LanzhouPeople’s Republic of ChinaAsiaCancerEmergingTechnologiesHealth and MedicineHemic and Immune SystemsImmunologyLymph NodesLymphoid TissueMachine LearningOncologyRoboticsRobotsTesticular CancerTesticular Diseases and Conditions
NETL
NSTL
